Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management

Kostakou, Eirini; Kaniaris, Evangelos; Filiou, Effrosyni; Vasileiadis, Ioannis; Κatsaounou, Paraskevi; Tzortzaki, Eleni G.; Koulouris, Νikolaos; Koutsoukou, Antonia; Ρovina, Νikoletta

doi:10.3390/jcm8091283

Cited by 38 publications

(30 citation statements)

References 283 publications

(329 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Such presentations may indicate that the patient has severe disease, or that self-management has been inadequate to protect from exacerbations. 1,2 Therefore, following acute management to stabilise the patient, subacute asthma care is critical to ensure patients are discharged safely, understand appropriate self-management of asthma and receive appropriate specialist follow up. National asthma guidelines for the optimisation and standardisation of care are readily available and detailed in the Australian Asthma Handbook.…”

mentioning

confidence: 99%

Post‐acute care for asthma patients presenting to an Australian hospital network

Huang

Liu

Hew

et al. 2021

Internal Medicine Journal

View full text Add to dashboard Cite

We evaluated post‐acute care in 1273 asthma patients presenting to our hospital network. Patients with respiratory unit admission (n = 413) or consultation from the respiratory service (n = 45) were more likely to have guideline adherent care compared with patients without respiratory input (n = 153). Patients aged greater than 60 years had higher rates of representation within 90 days and lower rates of asthma action plans. Post‐acute care of asthma at our centre falls short of guideline recommendations, and subspecialist involvement should be expanded.

show abstract

mentioning

confidence: 99%

Post‐acute care for asthma patients presenting to an Australian hospital network

Huang

Liu

Hew

et al. 2021

Internal Medicine Journal

View full text Add to dashboard Cite

show abstract

“…These reports and our finding were not against the global initiative for asthma 2019 (GINA 2019) [67]. The ICSs will play a more important role than the OSs especially in mild asthma and in the escalation pathway of the eosinophilic COPD with triple combination-therapy [49].…”

Section: Discussionmentioning

confidence: 47%

Associations among chronic obstructive pulmonary disease with asthma, pneumonia, and corticosteroid use in the general population

2020

View full text Add to dashboard Cite

To evaluate the association among chronic obstructive pulmonary disease (COPD) with asthma, steroid use, and pneumonia in the general population. Methods Using Taiwan's National Health Insurance Research Database to identify patients with incident pneumonia, we established a COPD with asthma cohort of 12,538 patients and a COPD cohort of 25,069 patients. In both cohorts, the risk of incident pneumonia was assessed using multivariable Cox proportional hazards models. Results The adjusted hazard ratio (aHR) with 95% confidence interval (CI) for incident pneumonia was 2.38 (2.14, 2.66) in the COPD with asthma cohort, regardless of age, sex, comorbidities, and drug use. COPD cohort without inhaled corticosteroids (ICSs) use served as a reference. The aHR (95% CI) for COPD cohort with ICSs use was 1.34 (0.98, 1.83); that for COPD with asthma cohort without ICSs use was 2.46 (2.20, 2.76); and that for COPD with asthma cohort with ICSs use was 2.32 (1.99, 2.72). COPD cohort without oral steroids (OSs) use served as a reference; the aHR (95% CI) for COPD with asthma cohort without OSs use and with OSs use was 3.25 (2.72, 3.89) and 2.38 (2.07, 2.74), respectively.

show abstract

“…Возраст. С возрастом увеличивается число детей, нуждающихся в пребывании в отделении реанимации и интенсивной терапии в связи с развитием угрожающих жизни состояний на фоне базисной терапии ингаляционными кортикостероидами [16,17].…”

Section: предикторы развития жизнеугрожающей астмыunclassified

Life-threatening bronchial asthma in children: from predictors to prognosis

Potapova

2021

Ross. vestn. perinatol. pediatr.

View full text Add to dashboard Cite

Угрожающее жизни обострение бронхиальной астмы может возникнуть при любой тяжести заболевания. Определение предикторов фатального состояния позволит выделить группы высокого риска развития астматического статуса. В настоящее время традиционная интенсивная терапия астматического статуса дополнилась инновационными подходами в респираторной поддержке, бронходилатационной терапии, базисном сопровождении пациентов, перенесших жизнеугрожающую астму. К предикторам жизнеугрожающей бронхиальной астмы относят риновирусную инфекцию, тяжелое обострение в анамнезе, грибковую сенсибилизацию и возраст пациентов. Данное состояние на 25% увеличивает риск развития повторных угрожающих жизни обострений, что требует особого подхода к терапии и наблюдению пациентов на амбулаторном этапе. Данный обзор обращает внимание на современные подходы в терапии таких пациентов с целью унификации тактики ведения детей с астматическим статусом в Российской Федерации.

show abstract

Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management

Cited by 38 publications

References 283 publications

Post‐acute care for asthma patients presenting to an Australian hospital network

Post‐acute care for asthma patients presenting to an Australian hospital network

Associations among chronic obstructive pulmonary disease with asthma, pneumonia, and corticosteroid use in the general population

Life-threatening bronchial asthma in children: from predictors to prognosis

Contact Info

Product

Resources

About